Shinsuke Agehara, a UF/IFAS assistant professor of Horticultural Sciences based at the Gulf Coast Research and Education Center (GCREC) in Balm, has been leading research efforts for years into making artichokes less alternative and more mainstream for hungry growers in the Sunshine State.
OncoMyx Therapeutics, a privately-held oncolytic immunotherapy company, has extended its intellectual property (IP) portfolio to include an exclusive option to license IP rights for the use and delivery of myxoma virus to treat certain cancers from the University of Florida Research Foundation (UFRF).
UF startup Glint Pharmaceuticals, an ophthalmic pharmaceutical company that delivers medicated contact lenses to treat eye diseases, announces the start of a phase I safety study to treat corneal infections and superficial injuries.
University of Florida Health researchers are joining an ambitious global effort led by The Rockefeller Foundation to better track the coronavirus and its variants and set up a network of collaborators to stop any nascent pandemic in the future.
UF startup Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, announced the appointment of Kenji Fujita, MD, to the newly created position of Chief Medical Officer.
Following a record-breaking year of growth for Alachua’s biotechnology industry, the University of Florida’s programs for entrepreneurial incubation and innovation, UF Innovate, has hired a new director of incubation services who’s looking to continue the program’s upward trajectory.
UF medicinal chemists report promising results from a study focused on new ways to of treating several types of antibiotic-resistant bacteria, advances that may help in the battle against MRSA, tuberculosis and other infectious pathogens.